About this trial
Patients who have undergone arthrodesis of the first metatarsophalangeal joint due to hallux valgus or hallux rigidus are invited to participate in this study, which aims to investigate how the foot functions after this operation. Patients between 18 and 60 years of age at the time of surgery are eligible to participate. Questionnaires will be distributed to assess current sports function compared with function prior to surgery. Particular focus will be placed on function during cross-country skiing.
Eligibility criteria
Qualifiers
Patients who has underwent arthrodesis of the first metatarsofalangeal joint because of hallux rigidus or severe hallux valgus
Patients at age 18-60 at the date of surgery
At least one year follow-up, and maximum 5 years since surgery.
Disqualifiers
Non-Norwegian-speaking patients.
Impaired walking function.
Inability to cooperate.
Concomitant osteotomy of other metatarsals.
Trial design
Treatments tested in this trial
- Arthrodesis
Treatment groups
Locations
Sponsors and collaborators
Oslo University Hospital
Lead sponsor
Sorlandet Hospital HF
Collaborator